October 21, 2023 08:20 AM EDTUpdated October 23, 06:01 AM
Law

Ic­ahn law­suit calls for mil­lions in dam­ages, re­moval of Il­lu­mi­na board mem­bers

Jared Whitlock

Features Editor

A new­ly un­sealed law­suit filed by ac­tivist in­vestor Carl Ic­ahn al­leges that Il­lu­mi­na board mem­bers ig­nored an­titrust reg­u­la­tors when buy­ing Grail for $8 bil­lion, failed …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times